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Hepatocellular carcinoma (HCC) is the most common type of liver cancer and the third most 
common cause of cancer-related death. Over 90% of HCC cases develop on a cirrhotic liver – which 
may have resulted from a chronic hepatitis B or hepatitis C infection, alcohol abuse or obesity. 
Early detection of HCC remains a major challenge since alpha-fetoprotein (AFP), the most widely 
used biomarker for HCC surveillance and detection, has limited utility for early stage disease. 
However, Dr. Laura Beretta and colleagues from the Public Health Sciences Division recently 
identified a new blood biomarker that outperforms AFP in detecting HCC and may be a major step 
forward in early detection. 
Using mass spectrometry, proteomic profiling of a small number of plasma samples initially identified 
the phosphoprotein osteopontin as being significantly increased in HCC compared to cirrhosis. 
Osteopontin has previously been associated with tumor invasion, progression or metastasis in 
several other cancers.  Next, plasma osteopontin levels were measured in two distinct cohorts each 
comprised of patients with HCC, cirrhosis, chronic hepatitis C or B, and healthy controls. The first 
U.S.-based cohort included a majority of patients with hepatitis C and more cases of early-stage 
disease, while the second cohort, based in Thailand, included a majority of patients with hepatitis B 
and more cases of advanced disease. 
In the first cohort, mean osteopontin levels were significantly higher in HCC cases (271.4 ng/mL) 
than in cirrhosis (86.2 ng/mL), hepatitis C (52.6 ng/mL) or healthy controls (32 ng/mL). The 
predictive ability of osteopontin (Area Under the Curve (AUC)=0.76, 95% Confidence Interval (CI): 
0.66-0.85) was higher than for AFP (AUC=0.71, 95% CI: 0.60-0.82), while the combination of 
osteopontin and AFP further improved detection accuracy (AUC= 0.82, 95% CI: 0.73-0.91). When 
the sample was limited to hepatitis C-associated HCC and cirrhosis, osteopontin outperformed AFP 
to an even greater degree (AUC=0.80, 95% CI: 0.69-0.91 vs. 0.64, 95% CI: 0.49-0.80). 
In the second cohort, osteopontin levels were also higher in HCC compared with all other groups, 
and the AUC for osteopontin alone was higher than for AFP (0.93 95% CI: 0.88-0.98 vs. 0.86, 95% 
CI 0.80-0.92), while the combination of both markers was better still (0.96, 95% CI: 0.92-
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0.99).  Osteopontin also outperformed AFP when hepatitis B –associated cases were examined 
separately (AUC=0.97, 955CI: 0.94-1.00 vs. 0.90, 95% CI: 0.84-0.97). 
Finally, in a simultaneous pilot study of 22 patients from the U.S. cohort who developed HCC during 
follow-up, osteopontin levels were shown to be elevated at least 1 year prior to diagnosis. Thus, 
measurement of osteopontin may represent a valuable new opportunity towards improved screening 
and early detection of HCC. The results of future validation studies and long-term follow-up will be 
awaited with great interest. 
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Figure (courtesy of Dr. L Beretta) Plasma levels of 
osteopontin (OPN) among healthy individuals and 
those with chronic hepatitis C, cirrhosis and HCC from 
cohort 1. Box refers to the 25th and 75th percentile 
values, with a line indicating median levels; the 
interquartile range extends outside the box. Points 
outside the interquartile range are outliers. HCC had 
higher osteopontin plasma levels, compared with 
cirrhosis, hepatitis c, and healthy control groups (p < 
0.0001). 
 
